Alkermes Announces FDA Advisory Committee Recommends Approval of VIVITROL for Opioid Dependence

More info…
WALTHAM, Mass.—-Alkermes, Inc. today announced that the U.S. Food and Drug Administration Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL should be approved for the treatment of opioid dependence.

detox opiate